1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Drug Discovery and Development Analysis & Statistics, June 2015 (p30)

Drug Discovery and Development Analysis & Statistics, June 2015 (p30)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

871-900 of about 2 100 reports

Purchase Reports From Reputable Market Research Publishers

Xerostomia Global Clinical Trials Review, H1, 2015

Xerostomia Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Data

Xerostomia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Xerostomia Global Clinical Trials Review, H1, 2015" provides an overview of Xerostomia clinical trials ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Pancreatic Cancer - Pipeline Review, H1 2015

Pancreatic Cancer - Pipeline Review, H1 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Markets Direct

Pancreatic Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Thrombosis - Pipeline Review, H1 2015

Thrombosis - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Thrombosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Thrombosis’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Sarcopenia Global Clinical Trials Review, H1, 2015

Sarcopenia Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Data

Sarcopenia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Sarcopenia Global Clinical Trials Review, H1, 2015" provides an overview of Sarcopenia clinical trials ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015

Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Data

Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Pathology, Drug and Medication, Therapy
  • Countries : World
Hemorrhage Global Clinical Trials Review, H1, 2015

Hemorrhage Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Data

Hemorrhage Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hemorrhage Global Clinical Trials Review, H1, 2015" provides an overview of Hemorrhage clinical trials ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Hemodialysis Equipment - Pipeline Review, 2015

Hemodialysis Equipment - Pipeline Review, 2015

  • $ 2 500
  • Industry report
  • June 2015
  • by Global Data

Hemodialysis Equipment - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Hemodialysis Equipment - Pipeline Review, 2015" provides an overview of Hemodialysis Equipment currently ...

  • Industries : Medical Devices, Healthcare, Drug Discovery and Development
  • Countries : United States
Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H1, 2015

Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • June 2015
  • by Global Data

Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World, United States
Non-Invasive Blood Pressure Monitors - Pipeline Review, 2015

Non-Invasive Blood Pressure Monitors - Pipeline Review, 2015

  • $ 2 500
  • Industry report
  • June 2015
  • by Global Data

Non-Invasive Blood Pressure Monitors - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Non-Invasive Blood Pressure Monitors - Pipeline Review, 2015" provides an overview of ...

  • Industries : Hospitality, Hospitality, Medical Devices, Drug Discovery and Development, Cardiovascular Devices, Pharmaceutical, Healthcare
  • Countries : United States
Candidiasis Global Clinical Trials Review, H1, 2015

Candidiasis Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • June 2015
  • by Global Data

Candidiasis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Candidiasis Global Clinical Trials Review, H1, 2015" provides an overview of Candidiasis clinical trials ...

  • Industries : Drug Discovery and Development, Pathology, Pharmaceutical, Therapy
  • Countries : World
Hernia Global Clinical Trials Review, H1, 2015

Hernia Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • June 2015
  • by Global Data

Hernia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hernia Global Clinical Trials Review, H1, 2015" provides an overview of Hernia clinical trials scenario. This ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Pathology, Therapy
  • Countries : World
Escherichia Coli Infections Global Clinical Trials Review, H1, 2015

Escherichia Coli Infections Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • June 2015
  • by Global Data

Escherichia Coli Infections Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Escherichia Coli Infections Global Clinical Trials Review, H1, 2015" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Brain Injury Global Clinical Trials Review, H1, 2015

Brain Injury Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • June 2015
  • by Global Data

Brain Injury Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Brain Injury Global Clinical Trials Review, H1, 2015" provides an overview of Brain Injury clinical trials ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Human Papillomavirus Infections Global Clinical Trials Review, H1, 2015

Human Papillomavirus Infections Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • June 2015
  • by Global Data

Human Papillomavirus Infections Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Human Papillomavirus Infections Global Clinical Trials Review, H1, 2015" provides ...

  • Industries : Pathology, Pharmaceutical, Drug Discovery and Development, Therapy
  • Countries : World
Eurocor GmbH - Product Pipeline Analysis, 2015 Update

Eurocor GmbH - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Company report
  • June 2015
  • by Global Data

Summary Eurocor GmbH (Eurocor) a subsidiary of Opto Circuits India Limited is a life science technology company that conducts research, develops, manufactures and markets cardiovascular and endovascula ...

  • Industries : Cardiovascular Devices, Surgical Equipment
  • Countries : Germany, United States
BTG Plc (BTG) - Product Pipeline Analysis, 2015 Update

BTG Plc (BTG) - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Company report
  • June 2015
  • by Global Data

Summary BTG plc (BTG) is an international healthcare company that develops manufactures and sells innovative products in specialized areas of medicine. The company undertakes the development of specialty ...

  • Industries : Pathology, Pharmaceutical, Drug Discovery and Development
  • Countries : United States
High Content Screening (HCS) Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025

High Content Screening (HCS) Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025

  • $ 5 000
  • Industry report
  • June 2015
  • by Future Market Insight Global & Consulting Pvt Ltd

This Future Market Insights report examines the ‘High Content Screening (HCS)’ market for the period 2015–2025. New product launches are resulting in product assortment and thus, increased installation ...

  • Industries : Drug Discovery and Development
  • Countries : World
VEGF Signaling Pathway in Cancer Drug Pipeline Update 2015

VEGF Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

There is now much evidence that VEGFR-2 is the major mediator of VEGF-driven responses in endothelial cells and it is considered to be a crucial signal transducer in both physiologic and pathologic angiogenesis. ...

  • Industries : Drug Discovery and Development
Chemokine Signaling Pathway in Cancer Drug Pipeline Update 2015

Chemokine Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Inflammatory immune response requires the recruitment of leukocytes to the site of inflammation upon foreign insult. Chemokines are small chemoattractant peptides that provide directional cues for the ...

  • Industries : Drug Discovery and Development
Neuroendocrine Tumors Drug Pipeline Update 2015

Neuroendocrine Tumors Drug Pipeline Update 2015

  • $ 2 086
  • Industry report
  • June 2015
  • by Bioseeker

There are today 102 companies plus partners developing 105 neuroendocrine tumor drugs in 169 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated number of ceased ...

  • Industries : Drug Discovery and Development
Melanoma Drug Pipeline Update 2015

Melanoma Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Melanoma comprises just 5% of all skin cancers but it is the most deadly. High unmet needs still persist for this tumor type and despite three decades of extensive R&D, five-year survival of advanced patients ...

  • Industries : Drug Discovery and Development
NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2015

NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 2 086
  • Industry report
  • June 2015
  • by Bioseeker

Specific families of pattern recognition receptors are responsible for detecting various pathogens and generating innate immune responses. The intracellular NOD-like receptor (NLR) family contains more ...

  • Industries : Drug Discovery and Development
Cell Cycle Targeting in Cancer Drug Pipeline Update 2015

Cell Cycle Targeting in Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

There are today 164 companies plus partners developing 169 targeting the cell cycle drugs in 671 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ...

  • Industries : Drug Discovery and Development
Calcium Signaling Pathway in Cancer Drug Pipeline Update 2015

Calcium Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

There are today 245 companies plus partners developing 287 calcium signaling pathway targeting drugs in 1060 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated ...

  • Industries : Drug Discovery and Development
Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2015

Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

There are today 199 companies plus partners developing 206 metabolic pathways targeting drugs in 561 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated numbe ...

  • Industries : Drug Discovery and Development
Targeting Tight Junctions in Cancer Drug Pipeline Update 2015

Targeting Tight Junctions in Cancer Drug Pipeline Update 2015

  • $ 2 086
  • Industry report
  • June 2015
  • by Bioseeker

Epithelial tight junctions (TJs) are composed of at least three types of transmembrane protein -occludin, claudin and junctional adhesion molecules (JAMs)- and a cytoplasmic 'plaque' consisting of many ...

  • Industries : Drug Discovery and Development
Toll-Like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2015

Toll-Like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Specific families of pattern recognition receptors are responsible for detecting microbial pathogens and generating innate immune responses. Toll-like receptors (TLRs) are membrane-bound receptors identified ...

  • Industries : Drug Discovery and Development
ErbB Signaling Pathway in Cancer Drug Pipeline Update 2015

ErbB Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

The ErbB family of receptor tyrosine kinases (RTKs) couples binding of extracellular growth factor ligands to intracellular signaling pathways regulating diverse biologic responses, including proliferation, ...

  • Industries : Drug Discovery and Development
Interfering With the ECM-Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2015

Interfering With the ECM-Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2015

  • $ 1 046
  • Industry report
  • June 2015
  • by Bioseeker

The extracellular matrix (ECM) consists of a complex mixture of structural and functional macromolecules and serves an important role in tissue and organ morphogenesis and in the maintenance of cell and ...

  • Industries : Drug Discovery and Development
Modulators of the Actin Cytoskeleton for the Treatment of Cancer Drug Pipeline Update 2015

Modulators of the Actin Cytoskeleton for the Treatment of Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

There are today 251 companies plus partners developing 366 targeting actin cytoskeleton modulators drugs in 1471 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated ...

  • Industries : Drug Discovery and Development

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.